Pulling SEC filings + quote and writing the call…

Hagerty, Inc.
Next earnings Aug 3, 2026 · consensus $-0.09 EPS, $320M rev
Last earnings -2.1% on 2026-05-06
Niche market-leader compounding revenue 20%+ with inflecting profits and fat free cash flow — fairly, not cheaply, priced.
Revenue $678M · FY2025
Hagerty is the dominant insurer of collector cars and enthusiast vehicles, a sticky 40-year niche now wrapped in a marketplace (Broad Arrow auctions, BAC financing) and media ecosystem. The fundamentals are genuinely good: revenue has compounded every year from $323M (FY2021) to $678M (FY2025), +23.5% in the latest year, while net income inflected from a $61.4M loss in FY2021 to $149M in FY2025 (+90.6%). Cash generation backs the GAAP profit — operating cash flow was $219M against just $24.5M of capex, leaving roughly $195M of free cash flow. This is a high-quality, scaling franchise, not a story stock.
The forward catalyst is the Markel Fronting Arrangement, effective January 1, 2026, under which Hagerty Re 'controls 100% of the premium and assumes 100% of the risk' on policies written through Essentia, with underwriting and claims authority expanded 'to the maximum levels permitted by applicable law.' Management 'expect[s] these changes to result in increased profitability and additional control.' That is the bull case: more of the economics of its own book stays in-house. But it cuts both ways — the same filing warns that 'beginning on January 1, 2026, the benefit of our MGA services will be received by Hagerty Re and not Markel,' so 'we will not recognize commission revenue or the associated ceding commission expense' on that book. Combined with the simultaneous shift to Article 7 reporting (net investment income/gains now sit inside revenue), FY2026 headline comparability will be messy, and the company is taking on materially more catastrophe risk just after Helene, Milton, and the Southern California wildfires drove claims in H2-2024/Q1-2025.
Is HGTY a buy? The one-page verdict, explained →
BUY verdict with defined risk: the short call finances part of the long one; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $323M | $384M | $464M | $549M | $678M |
| Gross profit | — | — | — | — | — |
| Operating income | -$10.1M | -$67.6M | $10.4M | $66.4M | — |
| Net income | -$61.4M | $2.40M | $28.2M | $78.3M | $149M |
| Diluted EPS | -$0.56 | — | — | — | — |
| Net margin | -19.0% | 0.6% | 6.1% | 14.3% | 22.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001840776, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/29/2026, 10:18:27 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 6:18 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 3 sales
| 2026-07-01 | Briglia Jeffrey Edward President of Insurance | Tax | 4.89K @ $12.06 | $59.0K |
| 2026-07-01 | Bjornstad Henrik Waersted Director | Award | 10.1K | |
| 2026-07-01 | DELANEY KEVIN M Chief Accounting Officer | Sell | 9.44K @ $12.10 | $114K |
| 2026-07-01 | DELANEY KEVIN M Chief Accounting Officer | Tax | 2.52K @ $12.06 | $30.5K |
| 2026-06-30 | DELANEY KEVIN M Chief Accounting Officer | Sell | 905.00 @ $12.01 | $10.9K |
| 2026-05-15 | Kuczinski Anthony J Director | Buy | 9.50K @ $10.46 | $99.4K |
| 2026-04-07 | Harris Laurie Director | Sell | 5.53K @ $11.01 | $60.9K |
| 2026-04-01 | Kay Sabrina Director | Award | 11.9K | |
| 2026-04-01 | Harbert Randall Houston Director | Award | 11.9K | |
| 2026-04-01 | KAUFFMAN ROBERT I Director | Award | 11.9K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median